Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-25 @ 4:04 AM
Ignite Modification Date: 2025-12-26 @ 2:58 AM
NCT ID: NCT02061202
Description: None
Frequency Threshold: 5
Time Frame: 2 years
Study: NCT02061202
Study Brief: Inhaled Mometasone to Reduce Painful Episodes in Patients With Sickle Cell Disease
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
Mometasone Furoate 1 puff daily (220mcg) for 16 weeks 0 None 0 35 15 35 View
Placebo 1 puff daily for 16 weeks. Training inhaler that does not contain any medication (placebo) 0 None 0 17 5 17 View
Serious Events(If Any):
Other Events(If Any):

Other Events

Term Type Organ System Vocab View
Hoarseness of voice SYSTEMATIC_ASSESSMENT Respiratory, thoracic and mediastinal disorders CTCAE (Unspecified) View
Thrush SYSTEMATIC_ASSESSMENT Respiratory, thoracic and mediastinal disorders CTCAE (Unspecified) View
Sore Throat SYSTEMATIC_ASSESSMENT Respiratory, thoracic and mediastinal disorders CTCAE (Unspecified) View